Yahoo Finance

Todos Medical Enters into Binding Agreement to Acquire All 3CL Protease Biology-Related Assets and Intellectual Property from NLC Pharma

NEW YORK and TEL AVIV, Israel, Nov. 30, 2021 (GLOBE NEWSWIRE) -- Todos Medical, Ltd. (OTCQB: TOMDF), a comprehensive medical diagnostics and related solutions company, today announced it has entered ...
Yahoo Finance

Todos Medical Announces Positive 3CL Protease Inhibition In Vitro Data Against BA.1 and BA.2 Omicron SARS-CoV-2 Variants

New York, NY, and Tel Aviv, ISRAEL, April 04, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire --Todos Medical, Ltd. (OTCQB: TOMDF), a comprehensive medical diagnostics and related solutions company, today ...
Jalopnik

Medical Technician Builds Amazing Laverda Sidecar

10 years, 10,000 hours and $21,000 went in to converting this 1000cc Laverda 3CL into a custom sidecar. The result looks nothing like the original bike and like nothing else on the road. Built by ...
Nasdaq

Todos Medical’s 3CL Protease Inhibitor Supplement Tollovid™ Featured in Wellness Magazine

New York, NY, and Tel Aviv, ISRAEL, Sept. 13, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire --Todos Medical, Ltd. (OTCQB: TOMDF), a comprehensive medical diagnostics and related solutions company, today ...
Nasdaq

Todos Medical Partner NLC Pharma Assigns IP for Tollovir™, Tollovid™, and TolloTest™ into JV 3CL Pharma

3CL Pharma preparing crowdfunding to fund Tollovir EUA filing in hospitalized COVID patients and Tollovir, Tollovid and TolloTest clinical development for Long COVID Funding also to be used to support ...